Mega Lifesciences PCL | Mutual Funds
Mutual Funds that own Mega Lifesciences PCL
DFA Emerging Markets Small Cap Series
3,083,000
0.36%
-31,000
0.05%
01/31/2018
DFA Emerging Markets Core Equity Portfolio
2,915,100
0.34%
566,700
0.01%
04/30/2018
Henderson Global Fds. - Emerging Markets Opportunities
1,811,400
0.21%
94,700
1.1%
06/30/2018
EP Asia Small Companies Fund
1,300,000
0.15%
500,000
2%
04/30/2018
730,000
0.08%
0
1.11%
08/31/2018
Eaton Vance Global Macro Capital Opportunities Portfolio
598,400
0.07%
0
0.41%
06/30/2018
473,400
0.06%
-88,800
0.17%
03/31/2018
NEI Northwest Emerging Markets Fund
345,100
0.04%
-4,500
0.39%
03/31/2018
DFA Emerging Markets Social Core Equity Portfolio
304,800
0.04%
234,100
0.02%
04/30/2018
World Shariah Funds PCC Ltd. - Asian Pacific Fund
130,000
0.02%
130,000
2.23%
10/31/2017
| Address |
No. 120, Moo 11, Ample Tower
Bangkok BM 10260
Thailand
|
|
Employees
|
- |
| Website |
http://www.megawecare.com |
| Updated |
07/08/2019 |
| Mega Lifesciences Public Co. Ltd. engages in the manufacture, market, sale, and distribution of pharmaceutical, nutraceutical products, and consumer goods. It operates through the following segments: Brands; Distribution; and Original Equipment Manufacture (OEM). The Brands segment manufactures and sells goods. |
